콜레스테롤 검사 제품 및 서비스 시장 : 제품 유형별, 검사 유형별, 연령대별, 최종 사용자별 - 세계 전망(2025-2030년)

The Cholesterol Testing Products & Services Market was valued at USD 22.67 billion in 2023, expected to reach USD 24.13 billion in 2024, and is projected to grow at a CAGR of 6.52%, to USD 35.29 billion by 2030.

Cholesterol testing products and services encompass a wide range of tools and methodologies used to measure lipid levels in blood samples, aiding in the assessment and management of cardiovascular health. The necessity of these services stems from the growing prevalence of cardiovascular diseases, largely driven by lifestyle shifts, aging populations, and increased awareness of preventive healthcare. Applications extend from regular health check-ups in clinical settings to self-monitoring at home using portable test kits. Major end-users include hospitals, diagnostic laboratories, and individual consumers focused on home wellness. Within this market, factors such as technological advancements in testing methods, including the development of point-of-care devices and non-invasive tests, are significant growth drivers. Moreover, increasing government initiatives to promote preventive healthcare and the escalating burden of lifestyle-related diseases further offer growth potential. Opportunities lie in expanding digital health platforms that integrate cholesterol monitoring with overall health management systems, thereby providing comprehensive care solutions. However, challenges persist, including the high costs of advanced testing devices and limited access in emerging markets due to economic constraints. Additionally, regulatory compliance and maintaining the accuracy and reliability of test results pose ongoing challenges. There are opportunities for innovation, particularly in improving the affordability and accessibility of testing technologies, such as developing cost-effective testing kits and enhancing telemedicine solutions for remote monitoring. Moreover, advances in artificial intelligence and data analytics can be leveraged to deliver personalized health insights and predictive risk assessments. The market is highly competitive, with a trend toward consumer-centric solutions emphasizing convenience and ease of use. Firms focusing on integrated care solutions and cross-collaboration with digital health platforms are well-positioned to navigate the evolving landscape effectively.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cholesterol Testing Products & Services Market

The Cholesterol Testing Products & Services Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of high cholesterol and cardiac diseases
  • Increase in demand for over-the-counter cholesterol test kits
  • Growing awareness regarding routine screening of cholesterol level
• Market Restraints
  • Limited availability of diagnostic laboratories and lack of skilled professionals
• Market Opportunities
  • Technological advancements in cholesterol testing systems
  • Increasing awareness and adoption of preventive healthcare
• Market Challenges
  • Stringent regulatory policies for approval of cholesterol testing methods

Porter's Five Forces: A Strategic Tool for Navigating the Cholesterol Testing Products & Services Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cholesterol Testing Products & Services Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cholesterol Testing Products & Services Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cholesterol Testing Products & Services Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cholesterol Testing Products & Services Market

A detailed market share analysis in the Cholesterol Testing Products & Services Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cholesterol Testing Products & Services Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cholesterol Testing Products & Services Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cholesterol Testing Products & Services Market

A strategic analysis of the Cholesterol Testing Products & Services Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cholesterol Testing Products & Services Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Biogenix Inc. Pvt. Ltd., BioReference Health, LLC, Blooms The Chemist Management Services Ltd, Cell Biolabs Inc., Charles River Laboratories International, Inc., Clinical Reference Laboratory, Inc., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Jant Pharmacal Corporation, Laboratory Corporation of America Holdings, Max Healthcare Institute Limited, Merck KGaA, Metropolis Healthcare Limited, Portea Medical by Healthvista India Private Limited, Quest Diagnostics Incorporated, Randox Laboratories Ltd., Redcliffe Labs, Siemens Healthineers AG, SpectraCell Laboratories, Inc., SYNLAB International GmbH, The Boots Company PLC, Thermo Fisher Scientific Inc., Unilabs AB, and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Cholesterol Testing Products & Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Offering, market is studied across Product and Services. The Product is further studied across Consumables and Devices.
• Based on Test Type, market is studied across High-Density Lipoprotein Cholesterol Test, Low-Density Lipoprotein Cholesterol Test, Total Cholesterol Test, and Triglycerides Test.
• Based on Age Group, market is studied across Adults, Geriatric, and Pediatric.
• Based on End-Users, market is studied across Diagnostic Centers, Government Agencies, Hospitals, and Physicians & Providers.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of high cholesterol and cardiac diseases
    • 5.1.1.2. Increase in demand for over-the-counter cholesterol test kits
    • 5.1.1.3. Growing awareness regarding routine screening of cholesterol level
  • 5.1.2. Restraints
    • 5.1.2.1. Limited availability of diagnostic laboratories and lack of skilled professionals
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements in cholesterol testing systems
    • 5.1.3.2. Increasing awareness and adoption of preventive healthcare
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulatory policies for approval of cholesterol testing methods
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cholesterol Testing Products & Services Market, by Offering

• 6.1. Introduction
• 6.2. Product
  • 6.2.1. Consumables
  • 6.2.2. Devices
• 6.3. Services

7. Cholesterol Testing Products & Services Market, by Test Type

• 7.1. Introduction
• 7.2. High-Density Lipoprotein Cholesterol Test
• 7.3. Low-Density Lipoprotein Cholesterol Test
• 7.4. Total Cholesterol Test
• 7.5. Triglycerides Test

8. Cholesterol Testing Products & Services Market, by Age Group

• 8.1. Introduction
• 8.2. Adults
• 8.3. Geriatric
• 8.4. Pediatric

9. Cholesterol Testing Products & Services Market, by End-Users

• 9.1. Introduction
• 9.2. Diagnostic Centers
• 9.3. Government Agencies
• 9.4. Hospitals
• 9.5. Physicians & Providers

10. Americas Cholesterol Testing Products & Services Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Cholesterol Testing Products & Services Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Cholesterol Testing Products & Services Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Biogenix Inc. Pvt. Ltd.
• 3. BioReference Health, LLC
• 4. Blooms The Chemist Management Services Ltd
• 5. Cell Biolabs Inc.
• 6. Charles River Laboratories International, Inc.
• 7. Clinical Reference Laboratory, Inc.
• 8. Eurofins Scientific SE
• 9. F. Hoffmann-La Roche Ltd.
• 10. Jant Pharmacal Corporation
• 11. Laboratory Corporation of America Holdings
• 12. Max Healthcare Institute Limited
• 13. Merck KGaA
• 14. Metropolis Healthcare Limited
• 15. Portea Medical by Healthvista India Private Limited
• 16. Quest Diagnostics Incorporated
• 17. Randox Laboratories Ltd.
• 18. Redcliffe Labs
• 19. Siemens Healthineers AG
• 20. SpectraCell Laboratories, Inc.
• 21. SYNLAB International GmbH
• 22. The Boots Company PLC
• 23. Thermo Fisher Scientific Inc.
• 24. Unilabs AB
• 25. Zoetis Inc.